CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Czechia
8 of 8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Where
- Hradec Králové
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT07540221 - Phase 3Taking peopleA Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Where
- Brno
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- argenx
See details and how to joinNCT07091630 · EU 2025-520805-10-00 - Phase 2/3Taking peopleEfficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Novy Hradec Kralove
- Age
- 18 years and over
- People
- 201 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05327114 · EU 2023-508425-28-00 - Phase 3Taking peopleA Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Where
- Brno
- Age
- 18 years and over
- People
- 218 worldwide
- Run by
- argenx
See details and how to joinNCT06920004 · EU 2024-520097-36-00 - Phase 3Enrolling by invitationLong-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
- Where
- Brno, Prague
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Sanofi
See details and how to joinNCT06859099 · EU 2024-517032-22-00 - Phase 3Taking peopleA Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Brno, Novy Hradec Kralove, Ostrava, Pardubice, Prague 2
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00 - Phase 3Taking peopleA Phase III study to evaluate how the body processes Xembify in comparison to Gamunex-C and determine the safety and in people with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Where
- Hradec Králové
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to join2025-522165-30-00 - Phase 3Taking peopleA Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Where
- Hradec Králové
- Age
- 18 years and over
- People
- 59 worldwide
- Run by
- Takeda
See details and how to joinNCT06747351 · EU 2024-517450-95-00